Zhangzhou Pientzehuang Pharmaceutical reported 2.63M in Interest Income for its fiscal quarter ending in March of 2025.


Interest Income Change Date
Dianthus Therapeutics USD 3.4M 587K Jun/2025
Ionis Pharmaceuticals -0.66 0.29 Dec/2024
IQVIA Holdings USD 10M 1000K Jun/2025
Jiangsu Hengrui 177.52M 65.16M Jun/2025
Kangmei Pharma 4.31M 8.34M Sep/2024
Moderna USD 81M 9M Jun/2025
Revvity USD 10.08M 253K Mar/2025
Sh Fosun Pharma 87.03M 10.62M Jun/2025
Tectonic Therapeutic USD 1.74M 217K Dec/2024
WuXi AppTec 239.75M 35.34M Jun/2025
Xeris Pharmaceuticals USD 948K 38K Jun/2025
Zhangzhou Pientzehuang Pharmaceutical 2.63M 3.55M Mar/2025